Investment opportunities in agricultural biotech, precision irrigation and water conservation
As the UK announced its official Agri-Tech Strategy, the World Agri-Tech Investment Summit addressed the growing importance of advanced agricultural technologies in meeting global food demand, and the opportunities this presents for the investment community to engage with and support the development of agricultural innovation.
Two days of intensive discussion and networking featured:
What delegates had to say about the World Agri-Tech Investment Summit 2013:
“On the behalf of Valley Irrigation, we would like to thank World Agri-Tech Investment summit for bringing together Government representatives, NGOs, Agricultural input manufacturers and suppliers, Ag technology/service start-ups as well as investors in order to project the impact of technologies on the agricultural production value chain. The information presented as well as the exchange between panelists and attendants was rich and provided a good view of coming trends in the Ag space.” Francois Levesque, Director, International Dealer Development, Valley Irrigation
“I want to congratulate you on such a well-organised, informative and exciting event: it was a real pleasure to participate and as a fellow-organiser, I admired the sheer professionalism of the whole team and know how much it takes to make such an event run smoothly.” Anne Miller, Associate Director (Research), Environmental Sustainability Knowledge Transfer Network
I thought the Summit was excellent. Well run, professional and attended by a very good cross-section of the industry…and not too big. From our perspective, I particularly enjoyed the AgTech showcase. I look forward to taking part again next year.” Michael Dean, AgFunder
“Congratulations on the first World Agri-Tech Investment Summit. This was a good event with a diverse mixture of investors, government policy makers and Agri-tech companies. And, the event attracted participants from around the globe. Definitely a worthwhile venture – one worth repeating!” Dave Smardon, Bioenterprise Capital